Skip to content

Starting HIV treatment at CD4 count above 500 reduces the risk of serious illness and death by 44%, African Temprano trial shows

Christine Danel presenting at CROI 2015. Photo by Liz Highleyman, hivandhepatitis.com

Week-on, weekend-off treatment controls viral load in young people

Karina Butler, part of paediatric panel at CROI 2015. Photo by Liz Highleyman, hivandhepatitis.com

Disappointing result for tenofovir-gel microbicide shows that young women still lack HIV prevention methods they can use

Helen Rees at CROI 2015. Photo by Gus Cairns (aidsmap.com).

7-country study shows triple-drug combination superior for preventing infant HIV infection

Mary Glenn Fowler presenting at CROI 2015. Photo by Liz Highleyman, hivandhepatitis.com

Pre-exposure prophylaxis also stops 86% of HIV infections in Ipergay study

Jean-Michel Molina presenting at CROI 2015. Photo by Liz Highleyman, hivandhepatitis.com

Researchers may have caught HIV becoming more virulent

A more personalised approach to hepatitis C treatment may improve adherence and completion rates

VOICE trial: Microbicide gel may have stopped two out of three HIV infections – in the women who used it

No improvements in CD4 count at diagnosis in African patients in last decade